The analysis of the preexisting decreased expression of P-selectin and GPIIb/IIIa in HF patients before LVAD implantation potentially contributes to a better risk assessment of bleeding as a consequence of impaired platelet function. This evidence concerns the gene ITGA2B and hydrops fetalis.